248 related articles for article (PubMed ID: 3820624)
1. [Central nervous system involvement in non-Hodgkin's lymphoma].
Nishikori M; Sorachi K; Doi S; Arita Y; Kamesaki H; Ohno H; Kita K; Fukuhara S; Uchino H; Yamabe H
Rinsho Ketsueki; 1986 Nov; 27(11):2051-8. PubMed ID: 3820624
[No Abstract] [Full Text] [Related]
2. [Non-Hodgkin's lymphomas: staging and therapy].
Rossini F; Pioltelli P; Lanzi E; Casaroli I; Bolis S; Pogliani EM; Corneo G
Clin Ter; 1989 Mar; 128(6):387-400. PubMed ID: 2524325
[TBL] [Abstract][Full Text] [Related]
3. [Primary central nervous system lymphoma].
Makino K; Kuratsu J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():159-63. PubMed ID: 16201517
[No Abstract] [Full Text] [Related]
4. Primary central nervous system lymphoma.
Freilich RJ; DeAngelis LM
Neurol Clin; 1995 Nov; 13(4):901-14. PubMed ID: 8584003
[TBL] [Abstract][Full Text] [Related]
5. Primary malignant non-Hodgkin's lymphoma of the central nervous system.
Bonnín JM; Garcia JH
Pathol Annu; 1987; 22 Pt 1():353-75. PubMed ID: 3554121
[No Abstract] [Full Text] [Related]
6. [Primary intramedullary spinal cord lymphoma in HIV patients. MRI aspects].
Drouet A; Caminade V; Guilloton L; Brunot J; Crozes P; Ribot C
Rev Neurol (Paris); 1999 Dec; 155(12):1074-8. PubMed ID: 10637928
[TBL] [Abstract][Full Text] [Related]
7. [Primary non-Hodgkin lymphomas of the central nervous system].
Hutschenreuter M; Wildemann B; Schackert G; Herrmann R; Hacke W
Nervenarzt; 1991 Feb; 62(2):69-79. PubMed ID: 2034311
[TBL] [Abstract][Full Text] [Related]
8. [Neurological presentation of non-Hodgkin lymphoma: a diagnostic problem].
Taphoorn MJ; Bromberg JE; Dekker AW
Ned Tijdschr Geneeskd; 1997 Aug; 141(33):1593-7. PubMed ID: 9543763
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system involvement in non-Hodgkin's lymphoma.
Chung MY; Chang YC; Chen RC
Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):378-84. PubMed ID: 3598549
[No Abstract] [Full Text] [Related]
10. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome?
Schaller C; Kelly PJ
Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548
[TBL] [Abstract][Full Text] [Related]
11. [Primary non-Hodgkin's lymphoma of the brain].
Galteland E; Sivertsen EA; Lote K; Holte H; Kvaløy S
Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4524-6. PubMed ID: 9889638
[TBL] [Abstract][Full Text] [Related]
12. Multi-modality in management of primary malignant non-Hodgkin lymphomas of the central nervous system.
Mayer A; Slowik F; Németh G
Strahlenther Onkol; 1990 Oct; 166(10):678-82. PubMed ID: 2237753
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy and survival in CNS involvement in non-Hodgkin's lymphoma].
Schertel L; Mohring R; Hilje T
Rontgenpraxis; 1995 Apr; 48(4):113-9. PubMed ID: 7777941
[No Abstract] [Full Text] [Related]
14. Non-Hodgkin's lymphoma of the corpus vitreum.
Sizoo W; van Andel JG; Baarsma GS; Wielenga JJ
Neth J Med; 1988 Aug; 33(1-2):26-9. PubMed ID: 3247006
[No Abstract] [Full Text] [Related]
15. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
16. [Primary malignant lymphoma of the central nervous system--an increasingly more frequent tumor].
Doerr M; Schumacher M; Mohadjer M
Nervenarzt; 1987 Sep; 58(9):538-42. PubMed ID: 3670514
[No Abstract] [Full Text] [Related]
17. Non-Hodgkin's lymphoma occurring as pure central nervous system pathology.
Kalakunja A; Hardwicke F
Clin Adv Hematol Oncol; 2003 Sep; 1(9):554-5; discussion 555. PubMed ID: 16258448
[No Abstract] [Full Text] [Related]
18. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
20. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
